The primary audience for this guideline includeshealth-care professionals who are responsible fordeveloping national and local health-care protocolsand policies, as well as managers of maternal andchild health programmes and policy-makers in allsettings. The guideline will also be useful to thosedirectly providing care to pregnant women andpreterm infants, such as obstetricians, paediatricians,midwives, nurses and general practitioners. Theinformation in this guideline will be useful fordeveloping job aids and tools for pre- and in-servicetraining of health workers to enhance their delivery ofmaternal and neonatal care relating to preterm birth.
WHO recommendation on antenatal corticosteroid therapy for women at risk of preterm birth from 24 weeks to 34 weeks of gestation
Published November 2015
WHO recommendation on antenatal corticosteroid administration when preterm birth is considered imminent within 7 days of starting treatment, including within the first 24 hours
WHO recommendation on antenatal corticosteroid therapy for women at risk preterm birth with a single or multiple pregnancy
WHO recommendation on antenatal corticosteroid therapy in women with preterm prelabour rupture of membranes
WHO recommendation on antenatal corticosteroid therapy in women with chorioamnionitis at risk of preterm birth
WHO recommendation on antenatal corticosteroid therapy in women undergoing planned caesarean section at late preterm gestations (34–36+6 weeks)
WHO recommendation on antenatal corticosteroid therapy in women with hypertensive disorders at risk of preterm birth
WHO recommendation on antenatal corticosteroid therapy for women at risk of preterm birth of a growth-restricted fetus
WHO recommendation on antenatal corticosteroid therapy for women with pre-gestational and gestational diabetes at risk of preterm birth
WHO recommendation on use of either dexamethasone or betamethasone as the antenatal corticosteroid of choice
WHO recommendation on use of a single repeat course of antenatal corticosteroid
WHO recommendation on the use of tocolytic treatment for inhibiting preterm labour
WHO recommendation on the use of magnesium sulfate for fetal protection from neurological complications
WHO recommendation on routine antibiotic administration for women in preterm labour with intact amniotic membranes
WHO recommendation on antibiotic administration for women with preterm prelabour rupture of membranes
WHO recommendation on the prophylactic antibiotic of choice in women with preterm prelabour rupture of membranes
WHO recommendation on the optimal mode of birth for women in refractory preterm labour
WHO recommendation on provision of continuous Kangaroo mother care for preterm newborns
WHO recommendation on intermittent Kangaroo mother care for preterm neonates, if continuous Kangaroo mother care is not possible
WHO recommendation on provision of care in a thermo-neutral environment for newborns who cannot be given Kangaroo mother care
WHO recommendation on effectiveness of plastic bags/wraps in providing thermal care for preterm newborns immediately after birth
WHO recommendation on continuous positive airway pressure therapy for the treatment of preterm newborns with respiratory distress syndrome
WHO recommendation on the time for starting continuous positive airway pressure therapy for newborns with respiratory distress syndrome
WHO recommendation on surfactant replacement therapy for newborns with respiratory distress syndrome
WHO recommendation on the type of surfactant for surfactant replacement therapy in newborns with respiratory distress syndrome
WHO recommendation on the prophylactic administration of surfactant in preterm newborns
WHO recommendation on the early administration of surfactant in intubated preterm newborns with respiratory distress syndrome
WHO recommendation on oxygen therapy for preterm newborns
